# An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.

Study · id `cardio:ct-nct07661381` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07661381](<https://clinicaltrials.gov/study/NCT07661381>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07661381

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT07661381. Randomized; no masking; primary purpose supportive care. Start 2026-09 (anticipated); primary completion 2028-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT07661381, source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)
- Planned start: 2026-09 (anticipated) (ClinicalTrials.gov record NCT07661381, source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)
- Primary completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07661381, source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)
- Completion: 2028-12 (anticipated) (ClinicalTrials.gov record NCT07661381, source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT07661381, source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07661381-2026-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: An Online Lifestyle Program With an AI Lifestyle Coach and Continues Glucose Monitoring in Type 2 Diabetes.
- Acronym: PREVAIL
- Condition: Diabetes Type 2
- Intervention (Behavioral): Lifestyle program
- Intervention (Device): Lifestyle program + coach
- Intervention (Device): Lifestyle program + coach + CGM
- Lead sponsor: University of Twente
- Lead sponsor class: OTHER
- Collaborator: TNO
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: daf66d0e5c81d2972bd601aadc2829d6d61c5848445e0dc55c69d02a7ee0bab1
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
